You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Molgramostim

Showing 26 - 50 of 135
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Triple-Negative Breast Cancer Trial in Worldwide (Tiragolumab, Atezolizumab, Nab-paclitaxel)

Active, not recruiting
  • Triple-Negative Breast Cancer
  • Birmingham, Alabama
  • +23 more
Jan 19, 2023

Alzheimer Trial in Aurora (Sargramostim, Saline - comparator)

Recruiting
  • Alzheimer Disease
  • Aurora, Colorado
    University of Colorado Anschutz Medical Campus
Jul 19, 2022

Glioblastoma Trial in Durham (Human CMV pp65-LAMP mRNA-pulsed autologous DCs containing GM CSF, Temozolomide, Tetanus-Diphtheria

Suspended
  • Glioblastoma
  • Human CMV pp65-LAMP mRNA-pulsed autologous DCs containing GM CSF
  • +4 more
  • Durham, North Carolina
    Duke University Medical Center
Aug 16, 2022

Glioblastoma Multiforme, Glioblastoma, Malignant Glioma Trial in Gainesville, Orlando, Durham (pp65-shLAMP DC with GM-CSF,

Recruiting
  • Glioblastoma Multiforme
  • +4 more
  • pp65-shLAMP DC with GM-CSF
  • +4 more
  • Gainesville, Florida
  • +2 more
Jan 6, 2022

Ewings Sarcoma, Non Small Cell Lung Cancer, Liver Cancer Trial in United States (Vigil™)

Completed
  • Ewings Sarcoma
  • +2 more
  • Vigil™
  • West Palm Beach, Florida
  • +3 more
Mar 14, 2022

Neuroblastoma Trial in New York (Hu3F8 With GM-CSF)

Active, not recruiting
  • Neuroblastoma
  • Hu3F8 With GM-CSF
  • New York, New York
    Memorial Sloan Kettering Cancer Center
May 2, 2022

Hodgkin's Lymphoma, Lymphoid Leukemia, Lymphoma Trial in Richmond (mycophenolate mofetil, Sargramostim, Filgrastim)

Active, not recruiting
  • Hodgkin's Lymphoma
  • +17 more
  • mycophenolate mofetil
  • +2 more
  • Richmond, Virginia
    Virginia Commonwealth University/Massey Cancer Center
Dec 21, 2021

Platinum Sensitive Ovarian Cancer, Ovarian Cancer Trial in United States (FRa peptide plus Adjuvant (GM-CSF), Adjuvant (GM-CSF)

Terminated
Has Results
  • Platinum Sensitive Ovarian Cancer
  • Ovarian Cancer
  • FRα peptide plus Adjuvant (GM-CSF)
  • Adjuvant (GM-CSF) Alone
  • Birmingham, Alabama
  • +17 more
Nov 21, 2022

Advanced Lung Non-Small Cell Carcinoma, Non-Small Cell Carcinoma of Lung, TNM Stage 4 Trial in Boston (Granulocyte-Macrophage

Recruiting
  • Advanced Lung Non-Small Cell Carcinoma
  • Non-Small Cell Carcinoma of Lung, TNM Stage 4
  • Granulocyte-Macrophage Colony-Stimulating Factor
  • +4 more
  • Boston, Massachusetts
    Tufts Medical Center
Oct 3, 2022

Covid19 Trial in North Bethesda (COVID-19 Therapeutic Biologics - Spike-GM-CSF Protein Lactated Ringer's Injection)

Active, not recruiting
  • Covid19
  • COVID-19 Therapeutic Biologics - Spike-GM-CSF Protein Lactated Ringer's Injection
  • North Bethesda, Maryland
    Medicine Invention Design Incorporation (MIDI) - IORG0007849
Dec 2, 2021

Multiple Myeloma Trial in Baltimore (biological, drug, other)

Recruiting
  • Multiple Myeloma
  • GM-CSF vaccine
  • +4 more
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Jan 6, 2022

Advanced Colorectal Cancer Trial in China (Surufatinib,Camrelizumab,Irinotecan,GM-CSF)

Recruiting
  • Advanced Colorectal Cancer
  • Changzhou, Jiangsu, China
  • +4 more
Jun 11, 2021

Advanced Malignant Solid Tumor Trial in Hangzhou (biological, other, drug, procedure)

Recruiting
  • Advanced Malignant Solid Tumor
  • iNeo-Vac-P01
  • +3 more
  • Hangzhou, Zhejiang, China
    Run Run Shaw Hospital Affiliated to Zhejiang University School o
Apr 25, 2021

Autoimmune Pulmonary Alveolar Proteinosis Trial in Los Altos, Cincinnati (Sargramostim)

Completed
  • Autoimmune Pulmonary Alveolar Proteinosis
  • Los Altos, California
  • +1 more
Aug 2, 2021

Neuroblastoma Trial in New York (anti-GD2 murine IgG3 mAb 3F8)

Completed
Has Results
  • Neuroblastoma
  • anti-GD2 murine IgG3 monoclonal antibody 3F8
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Apr 21, 2022

Prostate Cancer Trial in New Brunswick, Seattle, Madison (pTVG-AR, gm-csf)

Completed
  • Prostate Cancer
  • pTVG-AR
  • gm-csf
  • New Brunswick, New Jersey
  • +2 more
Feb 2, 2021

Pouchitis Trial in Køge (GM-CSF, fosfomycin and metronidazole)

Recruiting
  • Pouchitis
  • GM-CSF, fosfomycin and metronidazole
  • Køge, Region Zealand, Denmark
    Zealand University Hospital
Sep 6, 2021

Breast Ductal Carcinoma In Situ Trial in United States (other, drug, biological, procedure)

Active, not recruiting
  • Breast Ductal Carcinoma In Situ
  • Laboratory Biomarker Analysis
  • +3 more
  • Boston, Massachusetts
  • +3 more
Jun 30, 2021

Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML) Trial run by the NHLBI

Completed
Has Results
  • Myelodysplastic Syndrome (MDS)
  • +2 more
  • WT1:126-134
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 15, 2021

Alzheimer's Disease Trial in Aurora (Sagramostim, Saline -- comparator)

Completed
Has Results
  • Alzheimer's Disease
  • Aurora, Colorado
    University of Colorado Denver, Anschutz Medical Campus
May 12, 2021

Cutaneous Leishmaniasis Trial in Manaus, Presidente Tancredo Neves (Sbv, Miltefosine plus , Miltefosine plus GM-CSF)

Completed
  • Cutaneous Leishmaniasis
  • Manaus, Amazonas, Brazil
  • +1 more
Apr 3, 2020

Melanoma (Skin) Trial in Beijing (OrienX010 injection, Dacarbazine (DTIC))

Recruiting
  • Melanoma (Skin)
  • OrienX010 injection
  • Dacarbazine (DTIC)
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Feb 25, 2020

Multiple Myeloma Trial in United States (procedure, drug, biological)

Completed
Has Results
  • Multiple Myeloma
  • Tumor Cell Collection
  • +6 more
  • San Francisco, California
  • +14 more
Jul 11, 2022

Melanoma Trial in Beijing (OrienX010 combination with JS001)

Recruiting
  • Melanoma
  • OrienX010 combination with JS001
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Dec 18, 2019

Breast Cancer Trial in Germany, Greece, United States (GP2 peptide + GM-CSF vaccine, GM-CSF (sargramostim), AE37 + GM-CSF

Completed
  • Breast Cancer
  • GP2 peptide + GM-CSF vaccine
  • +2 more
  • Washington, District of Columbia
  • +12 more
Mar 23, 2020